T2 Biosystems Receives $23,000,000 Series D Financing Round

  • Feed Type
  • Date
    8/10/2011
  • Company Name
    T2 Biosystems
  • Mailing Address
    101 Hartwell Avenue Lexington, MA 02421
  • Company Description
    T2 Biosystems is a newly formed diagnostics company ushering in a new wave of innovative products to improve medical decision-making and treatment. Our proprietary biosensor technology was invented by a team of world-renowned scientists at MIT and Massachusetts General Hospital. Using this technology, we are developing a range of diagnostic products to impact a variety of health care settings; from centralized testing laboratories to point of care.
  • Website
    http://www.t2biosystems.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $23,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    The proceeds from this round will support ongoing development and clinical trials as the Company moves towards regulatory approval and commercialization of their T2MR diagnostic technology, as well as enable expansion of the Company’s partnering program.
  • M&A Terms
  • Venture Investor
    Aisling Capital
  • Venture Investor
    Flagship Ventures
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Physic Ventures
  • Venture Investor
    Flybridge Capital Partners
  • Venture Investor
    Arcus Ventures
  • Venture Investor
    WS Investment
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.